What did the study reveal about testosterone levels and cancer progression? Researchers found that prostate cancer patients with low baseline testosterone levels (300 ng/dl and lower) had a ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

A healthy diet may slow the progression of early stage prostate cancer according to the results of a new study. Men with prostate cancer diagnosed at an early stage may be able to slow the progression ...

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Diet is increasingly seen as a modifiable risk factor in prostate cancer. Recent studies have shown that ultralow-carbohydrate diets, weight loss diets, supplementation with omega-3 fatty acids, pro- ...

Prostate cancer is among the most prevalent cancers in men, particularly above the age of 50. In India, prostate cancer has been increasingly reported, with the urban population being at a higher risk ...

HENRY H. WASHINGTON III, PHD, was in the U.S. Army for 25 years before he retired. But as it turned out, his transition from military service to civilian life came with prostate cancer.

J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory ...